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A best evidence topic in surgery was written according to a structured protocol. The question addressed
was in patients with oesophago-gastric junctional tumours which have been radiologically-staged as
potentially resectable, is diagnostic laparoscopy useful as an additional staging procedure. 292 papers
were found using the reported search, of which 5 represented the best evidence to answer the clinical
question. The authors, journal, date and country of publication, patient group, study type, relevant
outcomes and results of these papers are tabulated. We conclude that as an additional tool following
radiological staging of oesophago-gastric junctional tumours, diagnostic laparoscopy does appear to
detect previously occult peritoneal metastases as well as liver metastases and lymph nodes and these
ﬁndings do in turn lead to changes in management in over ten percent of patients. The procedure is
however associated with some morbidity and its efﬁcacy in changing management in the era of routine
PET scanning remains to be evaluated.
 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
A best evidence topic was constructed according to a structured
protocol as described in a previous publication.1
2. Clinical scenario
You are at a multi-disciplinary team meeting discussing
a patient with a biopsy-proven oesophago-gastric junctional (OGJ)
tumour. He has undergone computed tomography (CT) of the chest
and abdomen and endoscopic ultrasound (EUS) which have staged
him as a T3N1M0 adenocarcinoma. He is physiological ﬁt for
oesophagectomy however it is suggested that he undergo diag-
nostic laparoscopy prior to consideration for resection. You resolve
to check the literature to ascertain whether diagnostic laparoscopy
after radiological staging of OGJ tumours adds useful staging
information prior to resection?
3. Three-part question
In patients with radiologically-staged resectable disease
undergoing an oesophagectomy for an OGJ tumour, does laparos-
copy provide useful additional staging information?.
.
ciates Ltd. Published by Elsevier Lt4. Search strategy
Medline 1966 to January 2011 using the OVID interface for the
terms:
[staging] AND [laparoscopy] AND [oesophago-gastric] OR
[oesophageal] AND [cancer].
5. Search outcome
292 abstracts were found using the reported search. Using the
criteria outlined in a previous publication,1 we selected only those
papers which to directly assess the impact of laparoscopy on
staging and operative management. This yielded ﬁve papers which
provided the best evidence to answer the clinical question.
6. Results
The results of the ﬁve papers that provided the best evidence to
answer the question are summarised in Table 1.
7. Discussion
Despite improvements in the management of oesophageal
cancer long-term survival following surgical resection remains
poor. Part of the reason for this lies in the fact that many of the
patients undergoing resection have occult advanced disease at thed. All rights reserved.
Table 1
Best evidence papers.
Author, date
and country
Patient group Study type and
level of evidence
Outcomes Key results Comments
Heath et al,
(2000), [5]
USA
59 patients with
biopsy-proven oesophageal
cancer over a 54 month
period
All had good performance
status and were ﬁt to
undergo oesophagectomy
All patients who were
candidates for curative
treatment after EUS and
CT staging and then
underwent diagnostic
laparoscopy and lymph
node biopsy
Level IV
Retrospective
Study
Changes to
Staging
9 of 59 (15%)
Liver Metastases: 2 liver
metastases detected
Regional Lymph Nodes: 1
patient with radiologically
diagnosed node negative
disease was in fact positive
for tumour and upstaged.
2 patients with radiologically
diagnosed node-positive disease
were in fact negative for tumour
and downstaged.
Non-Regional Lymph Nodes: 2
patients with radiologically
diagnosed coeliac node disease
were tumour negative and were
downstaged.
No patient was upstaged
Peritoneal Metastases: 3
peritoneal metastases detected
(1also had a liver metastases)
This was a small, well-conducted
study looking only at patients
radiologically staged using EUS
and CT undergoing a diagnostic
laparoscopy and where technically
possible lymph node biopsy
(achieved in 75% of cases).
It demonstrated a change in
management in 17% of cases.
In the majority this was due
to laparoscopy detecting serosal
spread into the stomach,
necessitating a change in
operative strategy as opposed
to changes in TNM stage. In
addition 7% had occult peritoneal
or liver metastases detected by
DL alone.
With respect to lymph nodes,
DL and biopsy resulted in
downstaging of non-regional
lymph nodes in 2 patients
and upstaging of 1 patient
with regional lymph nodes.
Change to
management
10 of 59 (17%)
6 of 10 diagnosed with extension
to the gastric serosa and therefore
did not undergo oesophageal
resection.
4 of 10 diagnosed with M1 disease
and did not undergo resection
(as detailed above)
It should be noted that staging
laparoscopy was associated
with signiﬁcant morbidity.
Complications Mortality: 0 of 59 (0%)
Morbidity: 2 of 59 (3%)
1 case of small bowel perforation
requiring laparotomy and small
bowel resection
1case of intra-operative pulmonary
oedema from previously
undiagnosed aortic valve stenosis.
Bonavina et al.
(1997), [6]
Italy
50 patients consecutively
enrolled with distal
oesophageal and gastric
cardia tumours over a 13
month period
36 patients with biopsy
proven adenocarcinoma
of the cardia
14 patients with squamous
cell carcinoma of the lower
third of the oesophagus
All patients had been
investigated with CT
scan and US and
underwent diagnostic
laparoscopy at the same
sitting as planned surgical
resection
Level IV
Retrospective
Study
Changes to
Staging
5 of 50 (10%)
Liver Metastases: 1 patient with a
liver metastases detected on CT/US
in fact had a haemangioma detected
at DL and subsequently underwent
resection
Regional Lymph Nodes: Not
commented on
Non-Regional Lymph Nodes:
2 patients with node negative
coeliac disease on imaging were
upstaged at DL (however in 1 of
these patients it did not affect
management)
Peritoneal Metastases: 3 patients
had previously undetected peritoneal
carcinosis (1 of whom also had a
non-regional lymph node
involvement diagnosed at DL)
This study included both distal
oesophageal and gastric cardia
tumours.
As part of their pre-operative
radiological staging this study
used both CT and ultrasound of
the abdomen (but not EUS).
5 patients underwent changes
in staging due to DL- 1 was
downstaged, 1 was upstaged to
M1a disease, 2 was upstaged to
M1b and 1 was upstaged to both
M1a and M1b disease
Management was changed in a
total of 5 patients- 4 for
oncological reasons and in 1
for case non-oncological reasons
In addition to evaluating the role
of DL as an adjunct to radiological
staging, this study also looked at
DL in isolation. In comparison to
CT or US, DL was: 1) more
sensitive and speciﬁc for the
detection of lymph node
metastases
Change to
Management
5 of 50 (10%)
4 patients underwent changes in
management due to changes in
staging; 1 was diagnosed with
advanced liver cirrhosis and
deemed unﬁt for resection
2) more sensitive for the
detection of peritoneal and
liver metastases
Complications Mortality: 0 of 50 (0%)
Morbidity: 1 of 50 (0%)
(continued on next page)
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Table 1 (continued )
Author, date
and country
Patient group Study type and
level of evidence
Outcomes Key results Comments
This patient had moderate bleeding
from manipulation of a liver
haemangioma
Romijn el al.,
(1998), [7]
Netherlands
60 consecutive patients
with biopsy- proven cancer
of the oesophagus (40) or
gastric cardia (20) over a 27
month period were included
All patients had been staged
using: US of abdomen and
supraclavicular region; CT
chest and abdomen and EUS
Those with curative disease
were put forward for DL and
staging laparoscopic
ultrasound
Level IV
Retrospective
Study
Changes to
Staging
5 of 60 (8%)
Liver Metastases: 1 in 60
Regional Lymph Nodes:
Not commented on
Non-Regional Lymph Nodes:
None found on diagnostic
laparoscopy but 5 patients
with radiologically staged
node negative disease were
shown to have node positive
disease using laparoscopic
ultrasonography
Peritoneal Metastases: 4 in 60
This study concluded that
diagnostic laparoscopy had a
minor effect on the staging of
oesophageal cancer but was more
effective in staging of gastric
cardia tumours.
The paper also looked at the role
of laparoscopic ultrasonography
in conjunction with DL and
concluded that the addition
of LUS resulted in an increased
detection of coeliac lymph nodes
and liver metastases.
Change to
Management
5 of 60 (8%) DL itself led to
upstaging and hence the
abandonment of resection
in ﬁve cases as detailed above.
All of these cases were in
gastric cardia tumours.
As a consequence of laparoscopic
ultrasound as opposed to
DL itself, an additional ﬁve
cases of coeliac lymph node
involvement and two cases of
liver metastases were detected.
Complications Mortality: 0 of 60 (0%)
Morbidity: 0 of 60 (0%)
Heath et al,
(2000), [5]
USA
59 patients with biopsy-proven
oesophageal cancer over a 54
month period
All had good performance status
and were ﬁt to undergo
oesophagectomy
All patients who were candidates
for curative treatment after EUS
and CT staging and then
underwent diagnostic
laparoscopy and lymph node
biopsy
Level IV
Retrospective
Study
Changes to
Staging
9 of 59 (15%)
Liver Metastases: 2 liver
metastases detected
Regional Lymph Nodes:
1 patient with radiologically
diagnosed node negative
disease was in fact positive
for tumour and upstaged.
2 patients with radiologically
diagnosed node-positive
disease were in fact negative
for tumour and downstaged.
Non-Regional Lymph Nodes:
2 patients with radiologically
diagnosed coeliac node disease
were tumour negative and were
downstaged.
No patient was upstaged
Peritoneal Metastases:
3 peritoneal metastases
detected (1also had a liver
metastases)
This was a small, well-conducted
study looking only at patients
radiologically staged using EUS
and CT undergoing a diagnostic
laparoscopy and where technically
possible lymph node biopsy
(achieved in 75% of cases).
It demonstrated a change in
management in 17% of cases.
In the majority this was due
to laparoscopy detecting serosal
spread into the stomach,
necessitating a change in
operative strategy as opposed
to changes in TNM stage. In
addition 7% had occult peritoneal
or liver metastases detected by
DL alone.
With respect to lymph nodes,
DL and biopsy resulted in
downstaging of non-regional
lymph nodes in 2 patients and
upstaging of 1 patient with
regional lymph nodes.
It should be noted that staging
laparoscopy was associated with
signiﬁcant morbidity.
Krasna et al.,
(2002), [8]
USA
111 patients with pathologically
proven oesophageal cancer over
a 96 month period
53 Squamous Cell Carcinomas,
54 adenocarcinoma, 2 small cell
carcinoma, 2 poorly differentiated
carcinoma
All had been radiologically staged
using USS and CT.
In addition 85 had EUS and 59
underwent chest and abdominal
MRI.
A total of 76 patients underwent
DL (67 had DL and Thoracoscopy,
9 had DL alone)
35 had Thoracoscopy alone
Level IV
Retrospective
Study
Changes to
Staging
21 of 76 (28%)
Liver Metastases: 2 of 76
Regional Lymph Nodes:
3 patients with node-negative
regional disease on imaging
were upstaged at DL
Non-Regional Lymph Nodes:
16 patients with node-negative
coeliac disease on imaging
were upstaged at DL
Peritoneal Metastases Not
discussed in this paper
This study uses a bi-modal
minimally-invasive approach
to surgical staging. With reference
to the ﬁndings on laparoscopy
alone, it demonstrates the value
in DL as far as re-staging cancers
and discusses the usefulness of
visualising the peritoneum
directly in the detection of
metastases.
The study does not specify the
site at which the unexpected
lymph nodes were found
The paper also discusses the
relative sensitivities and
speciﬁcities of thoracoscopy
and laparoscopy.
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Table 1 (continued )
Author, date
and country
Patient group Study type and
level of evidence
Outcomes Key results Comments
de Graff et al.,
(2007) [4],
UK
416 patients with oesophago-
gastric cancer referred to two
UK hospitals over a 60 month
period were included.
All patients had been assessed
as ﬁt for surgery with curative
intent based on staging CT and
EUS in 48 patients, CT alone in
337 patients and abdominal
USS only in 31 patients.
Diagnostic laparoscopy was then
performed to assess resectability
of the tumour.
Level IV
Retrospective
Study
Change to
Management
18 of 76 (24%)
As detailed above
This was a retrospective study
analysing patients with
oesophageal and gastric
cancers. undergoing DL
following radiological staging.
They showed that DL led to
changes in management in
20% of cases. In addition, of
those deemed resectable at
DL, 27 (8.1%) were
subsequently found to be
unresectable at laparotomy
based on locally advanced
disease (16) or undetected
metastases (11).
Although this was a large
scale study, it should be
noted that the cohort had
undergone non-standardised
radiological staging for their
tumours.
Complications Mortality: 0 of 76 (0%)
Morbidity: 0 of 76 (0%)
1 laparoscopy was aborted
due to peritoneal adhesions
Changes to
Staging
89 of 416 (21%)
Liver Metastases: 18 patients
were found to have liver
metastases not diagnosed
radiologically.
Regional Lymph Nodes:
Not stated in the paper
Non-Regional Lymph Node
Involvement: 4 patients were
upstaged based on previously
undiagnosed non-regional
lymph node involvement.
Peritoneal Metastases: 50
patients were found to have
undiagnosed peritoneal
metastases
Changes to
Management
84 of 416 (20%)
63 patients had metastases
(13 with liver metastases,
45 with peritoneal disease
and 5with both); 4 had
non-regional lymph node
involvement and 17 had
locally advanced disease
Complications Mortality: 0 of 416 (0%)
Morbidity: 0 of 416 (0%)
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focus on accurate pre-operative staging of oesophageal cancers to
detect non-regional lymph node involvement, peritoneal disease
and distant metastases in order to prevent futile surgery on
patients with non-surgically curable disease. Over the last twenty
years there has been increasing use of CT and EUS as routine pre-
operative staging modalities for oesophageal cancer.2 Diagnostic
laparoscopy (DL) is awell-established procedure in its own right for
staging a number of intra-abdominal cancers and has been shown
to be useful in detecting lymphadenopathy, peritoneal and liver
metastases.3
With respect to the efﬁcacy of DL as an adjuvant staging therapy
following radiological staging of tumours, the earliest study was
performed by Bonavina et al.6who analysed a cohort of patientswith
distal oesophageal and gastric cardia tumours who had been staged
radiologically using CT and ultrasound. These patients underwent
a staging laparoscopy and if this was clear proceeded to oesopha-
gectomy at the same sitting. In this study, DL changed the treatment
plan in 10% of patients. In addition to evaluating the role of DL as an
adjunct to radiological staging, this study also looked at DL in isola-
tion and concluded itwas amore sensitive staging test than either CT
or US. It should be noted however that the study did not compare DL
against the combined information obtained fromboth CTandUS and
as such does not comment on the relative efﬁcacy of DL as compared
to the synergistic information from all radiological scanning.
Romijn et al.7 conducted a study in which biopsy-proven oeso-
phageal or gastric cardia cancer patients who had been radiologi-
cally staged using ultrasound, CT and EUS underwent DL together
with laparoscopic ultrasonography (LUS). DL resulted in a change in
management in 13% of their population- in all cases due to the
detection of peritoneal or liver metastases. This study did not
evaluate the role of DL in the detection of occult lymph nodeinvolvement; instead preferring to use LUS for this purpose. Inter-
estingly they found that LUS was useful in the detection of occult
coeliac lymph node involvement. Their overall conclusion was that
DL is of little beneﬁt in oesophageal carcinoma but had more of
a role in the staging of gastric cardia tumours.
Heath et al.5 performed a small retrospective study on patients
with biopsy-proven oesophageal cancers, all of whom had under-
gone staging using CTand EUS. This study demonstrated that DL led
to a change in treatment in 17% of their population. In the majority
this was due to laparoscopy detecting serosal spread into the
stomach, necessitating a change in operative strategy as opposed to
changes in oncological stage- however 7% of patients had occult
peritoneal or liver metastases detected by DL alone. In addition
Heath et al2 utilised DL to attempt to perform routine lymph node
biopsies although this was only technically achievable in 75% of
cases. This strategy of lymph node biopsy did but did lead to
changes in the status of regional lymph nodes but did not lead to
any change in management of the cancers. With respect to the
operative procedure itself, the mean hospital stay was 2 days and
there were signiﬁcant complications in 2 patients. The authors did
however note that DL could be used a therapeutic procedure to
insert a feeding jejenostomy in the cases where the tumours were
discovered to be unresectable.
Krasna et al.8 examined 111 patients with pathologically proven
oesophageal cancer; all of whom had been pre-operatively radio-
logically staged using CT and USS and in some cases EUS and MRI.
These patients then underwent minimally-invasive staging using
combined thoracoscopy and laparoscopy (in 67 patients), thor-
acoscopy alone (in 35 patients) or laparoscopy alone (in 9 patients).
With respect to the 76 patients who underwent DL, this procedure
resulted in upstaging in 21 patients- the majority being due to the
diagnosis of previously occult coeliac lymph node involvement.
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changes in management made as a result of thoracoscopy or
laparoscopy it does appear from analysing the data that DL led to
changes in management in 24% of cases. They also concluded that
DL itself has a higher sensitivity and speciﬁcity for the detection of
lymph node involvement as compared to combined radiological
staging. Although the study has a large number of patients it should
be noted that the cohort was heterogeneous with regard to histo-
logical cell type and as previously discussed there was no uniform
radiological staging for all patients.
The largest and most recent study on this topic was undertaken
by de Graaf et al.4 This retrospective study was conducted on 416
patients with oesophago-gastric cancer who were staged preoper-
atively based on CTand/or EUS or abdominal ultrasound. Diagnostic
laparoscopy resulted in changes to staging 21% of the patients with
20% becoming non-operable mainly due to the diagnosis of previ-
ously undetected peritoneal carcinomatosis. It should be noted
however that although this was a large- scale study, patients did not
undergo standardised radiological staging and this study failed to
distinguish between oesophageal, junctional and gastric tumours,
choosing instead to treat themas a single cohort. In addition, there is
a paucity of information on the exact ﬁndings on laparoscopy- for
example 17 patients were deemed unresectable due to the presence
of “locally advanced disease” but there is not information as to
exactly what this term entailed.
On reviewing all of these studies, it is striking that there are that
no randomised-controlled trials on the role of DL and most of the
studies involved relatively small populations with signiﬁcant
heterogeneity with regard to the tumour location and the radio-
logical techniques used to stage the cancers. In addition, the
majority of these studies are include patients operated over
a decade ago and as such pre-date the publication of the MRC
study9 on the efﬁcacy of pre-operative chemotherapy and the
introduction of routine positron emission tomography (PET) as
a staging modality. Given the documented efﬁcacy of this radio-
logical tool in detecting occult disseminated disease,10 it is unclear,
in the era of routine neoadjuvant chemotherapy and PET, whether
the ﬁnding that DL provides useful additional staging information
is still applicable. Finally it should be noted that although the
addition of DL does appear to be superior to radiological imaging
alone in detecting occult disseminated disease, it is still associated
in these studies with a false negative rate of approximately 5%.
8. Clinical bottom line
As an additional staging tool following radiological staging
of OGJ tumours, diagnostic laparoscopy does appear to detect
previously occult peritoneal metastases as well as liver metastasesand lymph nodes. These ﬁndings in turn lead to changes in
management in over ten percent of patients. The procedure is
however associated with some morbidity and its efﬁcacy in
changing management in the era of routine PET scanning remains
to be evaluated.
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